Country: United States
Language: English
Source: NLM (National Library of Medicine)
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC)
Azur Pharma, Inc.
DOCONEXENT
DOCONEXENT 250 mg
PRESCRIPTION DRUG
unapproved drug other
NATELLE ONE - NATELLE ONE CAPSULE, GELATIN COATED AZUR PHARMA, INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- NATELLE®ONE RX PRENATAL VITAMIN & PLANT-BASED DHA DESCRIPTION Natelle® One capsules for oral administration are supplied as oblong red soft gelatin capsules, imprinted with "Natelle1" in white ink. EACH CAPSULE CONTAINS: Docosahexaenoic Acid (DHA) .....................................................250 mg Eicosapentaenoic Acid (EPA).......................................................Not more than 0.625mg Calcium (Tricalcium Phosphate)...................................................100 mg Iron (Ferrous Fumarate) ..................................................................27 mg Vitamin C (Ascorbic Acid) .............................................................30 mg Vitamin B-6 (Pyridoxine HCl) ........................................................25 mg Vitamin E (D-Alpha Tocopherol) ....................................................30 IU Folic Acid ...........................................................................................1 mg DHA is an OMEGA-3 FATTY ACID. The DHA in Natelle® One is derived from the oils of microalgae. OTHER INGREDIENTS: Gelatin (Bovine), Beeswax, Glycerine, Soybean Oil, Lecithin, Titanium Dioxide, Ethyl Vanillin. INDICATIONS AND USAGE Natelle® One is indicated to provide vitamin/mineral and omega–3 fatty acid supplementation to women throughout pregnancy, during the postnatal period for both lactating and non–lactating mothers, and throughout the childbearing years. Natelle® One may be beneficial in improving the nutritional status of women prior to conception. CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN CHILDREN UNDER 6. Read the complete document